Free Trial
NASDAQ:VOR

Vor Biopharma (VOR) Stock Price, News & Analysis

Vor Biopharma logo
$31.05 +3.11 (+11.13%)
As of 01:16 PM Eastern

About Vor Biopharma Stock (NASDAQ:VOR)

Advanced

Key Stats

Today's Range
$26.68
$33.15
50-Day Range
$27.24
$48.40
52-Week Range
$2.62
$65.80
Volume
408,662 shs
Average Volume
379,908 shs
Market Capitalization
$196.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Vor Biopharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

VOR MarketRank™: 

Vor Biopharma scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vor Biopharma is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vor Biopharma is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    28.17% of the float of Vor Biopharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Vor Biopharma has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vor Biopharma has recently increased by 7.44%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Vor Biopharma does not currently pay a dividend.

  • Dividend Growth

    Vor Biopharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    28.17% of the float of Vor Biopharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Vor Biopharma has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vor Biopharma has recently increased by 7.44%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Vor Biopharma has a news sentiment score of -0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Manufacturing companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Vor Biopharma this week, compared to 1 article on an average week.
  • Search Interest

    24 people have searched for VOR on MarketBeat in the last 30 days. This is an increase of 167% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vor Biopharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.45% of the stock of Vor Biopharma is held by insiders.

  • Percentage Held by Institutions

    97.29% of the stock of Vor Biopharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vor Biopharma's insider trading history.
Receive VOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vor Biopharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VOR Stock News Headlines

Vor Biopharma (NASDAQ:VOR) vs. Prime Medicine (NASDAQ:PRME) Financial Contrast
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Vor Biopharma Inc. (VOR) - Yahoo Finance
See More Headlines

VOR Stock Analysis - Frequently Asked Questions

Vor Biopharma's stock was trading at $21.20 at the start of the year. Since then, VOR stock has increased by 31.7% and is now trading at $27.92.

Vor Biopharma Inc. (NASDAQ:VOR) released its earnings results on Tuesday, August, 12th. The company reported ($43.60) earnings per share for the quarter, missing the consensus estimate of ($11.40) by $32.20.

Shares of Vor Biopharma reverse split before market open on Thursday, September 18th 2025.The 1-20 reverse split was announced on Thursday, September 18th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 18th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Vor Biopharma (VOR) raised $150 million in an IPO on Friday, February 5th 2021. The company issued 8,800,000 shares at $16.00-$18.00 per share. Goldman Sachs, Evercore ISI, Barclays and Stifel served as the underwriters for the IPO.

Shares of VOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/12/2025
Today
9/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological Products, Except Diagnostic Substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VOR
Previous Symbol
NASDAQ:VOR
CIK
1817229
Web
N/A
Fax
N/A
Employees
140
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
6,330,000
Free Float
6,305,000
Market Cap
$176.80 million
Optionable
N/A
Beta
2.05

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:VOR) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners